Show simple item record

dc.contributor.authorLoretz, Brigitta
dc.contributor.authorSchneider-Daum, Nicole
dc.contributor.authorWindbergs, Maike
dc.contributor.authorSchaefer, Ulrich
dc.contributor.authorSchneider, Marc
dc.contributor.authorLehr, Claus Michael
dc.date.accessioned2017-08-29T09:32:31Z
dc.date.available2017-08-29T09:32:31Z
dc.date.issued2017-09
dc.identifier.citationBarriers and motivations for non-invasive drug delivery. 2017, 118:1-2 Eur J Pharm Biopharmen
dc.identifier.issn1873-3441
dc.identifier.pmid28433785
dc.identifier.doi10.1016/j.ejpb.2017.04.016
dc.identifier.urihttp://hdl.handle.net/10033/621078
dc.descriptionEditorial anlässlich der Special Issue zu unserer BioBarriers Konferenz von 2016.en
dc.language.isoenen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.titleBarriers and motivations for non-invasive drug delivery.en
dc.typeEditorialen
dc.contributor.departmentHIPS, Helmholtz-Institut für pharmazeutische Forschung Saarland, Universitätscampus E8.1,66123 Saarbrücken, Germany.en
dc.identifier.journalEuropean journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.Ven
refterms.dateFOA2018-09-15T00:00:00Z


Files in this item

Thumbnail
Name:
Publisher version
Thumbnail
Name:
Loretz et al.pdf
Size:
111.2Kb
Format:
PDF
Description:
original manuscript

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by-nc-sa/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-sa/4.0/